---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/297806082.md"
description: "Telix Pharmaceuticals shares are trading higher after HC Wainwright & Co. reiterated its Buy rating on the stock and maintained a $20 price target."
datetime: "2026-09-02T14:53:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/297806082.md)
  - [en](https://longbridge.com/en/news/297806082.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/297806082.md)
generator: "portal-rs"
---

# 

Telix Pharmaceuticals shares are trading higher after HC Wainwright & Co. reiterated its Buy rating on the stock and maintained a $20 price target.

### Related Stocks

- [TLX.US](https://longbridge.com/en/quote/TLX.US.md)
- [TLX.AU](https://longbridge.com/en/quote/TLX.AU.md)

## Related News & Research

- [Telix Completes Enrollment in Phase 3 BiPASS Study, Aligns with FDA on NDA Pathway | TLX Stock News](https://longbridge.com/en/news/297704266.md)
- [Telix Appoints David Gill as Chair | TLX Stock News](https://longbridge.com/en/news/297567288.md)
- [Telix Doses First Patient in Phase 3 LUTEON Trial of TLX250-Tx for Renal Cancer | TLX Stock News](https://longbridge.com/en/news/293255753.md)
- [Telix opens radiopharmaceutical facility in Australia for cancer treatment](https://longbridge.com/en/news/292888971.md)
- [First Patients Dosed in OPTIMAL-e Trial for Earlier Stage Prostate Cancer | TLX Stock News](https://longbridge.com/en/news/292813084.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**